Mark A. Blinn
Mark A. Blinn's purchase track record
Mark A. Blinn has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/23/2024 | LEG | $64K | +15.3% | +7.5% | +12.9% |
| 4/25/2024 | GL | $154K | +18.3% | +45.6% | +15.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
TXN Announces Q3 Earnings Preview and Q4 2026 Dividend. Texas Instruments will report Q3 earnings next week, with analysts noting key metrics that could influence expectations. The board also declared a quarterly dividend for Q4 2026, adding to shareholder value. These developments keep the stock in focus for investors monitoring earnings performance and dividend policy.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Globe Life (GL) Seen as Discounted with Strong Dividends and Buybacks. Analysts highlighted Globe Life’s discounted valuation, noting a trailing P/E of about 10.5 and a dividend that is increasing. The reports also point to aggressive share buybacks and solid fundamentals that may help the company outperform its financial‑services peers. Some commentary mentions low‑volatility characteristics but raises questions about the strength of those fundamentals.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Mizuho Maintains Outperform on Emerson Electric, Raises Target. Mizuho maintained its Outperform rating on Emerson Electric and raised its price target to $180, showing continued analyst support. This action reflects the broader bullish Wall Street sentiment surrounding the company. In the wider industrial sector, peer firms like Eaton and Dover are also drawing attention as market participants evaluate their respective positions.
Transaction History
| Q | ▲ Buy | Grant | 1,278 | $0 | 5/21/2026 | View on chart |
| TXN | ▼ Sell | Open Market | 6,000 | $1.7M | 4/24/2026 | View on chart |
| TXN | ▼ Sell | Open Market | 6,000 | $1.7M | 4/24/2026 | View on chart |
| TXN | ▼ Sell | Open Market | 3,000 | $836K | 4/24/2026 | View on chart |
| GL | ▼ Sell | Open Market | 1,750 | $259K | 2/6/2026 | View on chart |
| TXN | ▼ Sell | Open Market | 3,144 | $697K | 2/5/2026 | View on chart |
| TXN | ▲ Buy | Option Exercise | 628 | $110K | 2/5/2026 | View on chart |
| TXN | ▲ Buy | Option Exercise | 540 | $94K | 2/5/2026 | View on chart |
| TXN | ▲ Buy | Option Exercise | 767 | $128K | 2/5/2026 | View on chart |
| TXN | ▲ Buy | Option Exercise | 637 | $119K | 2/5/2026 | View on chart |
| EMR | ▼ Sell | Open Market | 1,400 | $213K | 2/5/2026 | View on chart |
| EMR | ▼ Sell | Open Market | 1,476 | $226K | 2/5/2026 | View on chart |
| EMR | ▲ Buy | Grant | 1,251 | — | 2/3/2026 | View on chart |
| TXN | ▲ Buy | Grant | 525 | $0 | 1/29/2026 | View on chart |
| GL | ▲ Buy | Grant | 1,373 | $0 | 1/2/2026 | View on chart |
| Q | ▲ Buy | Grant | 4,364 | $0 | 12/3/2025 | View on chart |
| TXN | ▼ Sell | Open Market | 0 | $72 | 7/21/2025 | View on chart |
| TXN | ▲ Buy | Option Exercise | 2,457 | $416K | 2/19/2025 | View on chart |
| TXN | ▲ Buy | Option Exercise | 1,079 | $188K | 2/19/2025 | View on chart |
| TXN | ▲ Buy | Option Exercise | 766 | $128K | 2/19/2025 | View on chart |
| TXN | ▲ Buy | Option Exercise | 1,884 | $329K | 2/19/2025 | View on chart |
| TXN | ▼ Sell | Open Market | 6,186 | $1.2M | 2/19/2025 | View on chart |
| EMR | ▼ Sell | Open Market | 20 | $3K | 2/12/2025 | View on chart |
| EMR | ▼ Sell | Open Market | 1,867 | $235K | 2/10/2025 | View on chart |
| TXN | ▼ Sell | Open Market | 590 | $107K | 2/4/2025 | View on chart |
| EMR | ▲ Buy | Grant | 1,476 | — | 2/4/2025 | View on chart |
| TXN | ▲ Buy | Grant | 614 | $0 | 1/27/2025 | View on chart |
| GL | ▼ Sell | Open Market | 3,000 | $340K | 1/6/2025 | View on chart |
| GL | ▲ Buy | Grant | 1,604 | $0 | 1/2/2025 | View on chart |
| LEG | ▲ Buy | Open Market | 6,000 | $64K | 5/23/2024 | View on chart |
| GL | ▲ Buy | Open Market | 2,000 | $154K | 4/25/2024 | View on chart |
| LEG | ▲ Buy | Grant | 7,887 | $160K | 2/26/2024 | View on chart |
| EMR | ▼ Sell | Open Market | 2,413 | $249K | 2/9/2024 | View on chart |
| EMR | ▲ Buy | Grant | 1,867 | — | 2/6/2024 | View on chart |
| TXN | ▲ Buy | Option Exercise | 978 | $128K | 1/31/2024 | View on chart |
| TXN | ▼ Sell | Open Market | 978 | $156K | 1/31/2024 | View on chart |
| TXN | ▼ Sell | Open Market | 766 | $122K | 1/31/2024 | View on chart |
| TXN | ▲ Buy | Grant | 686 | $0 | 1/25/2024 | View on chart |
| GL | ▲ Buy | Grant | 1,475 | $0 | 1/2/2024 | View on chart |
| EMR | ▼ Sell | Gift | 69 | — | 3/2/2023 | View on chart |
| TXN | ▼ Sell | Other | 600 | $0 | 2/23/2023 | View on chart |
| TXN | ▼ Sell | Gift | 600 | $0 | 2/23/2023 | View on chart |
| TXN | ▼ Sell | Gift | 600 | $0 | 2/23/2023 | View on chart |
| EMR | ▲ Buy | Grant | 1,933 | — | 2/7/2023 | View on chart |
| TXN | ▲ Buy | Option Exercise | 1,133 | $118K | 2/3/2023 | View on chart |
| TXN | ▲ Buy | Option Exercise | 978 | $128K | 2/3/2023 | View on chart |
| TXN | ▼ Sell | Open Market | 3,068 | $557K | 2/3/2023 | View on chart |
| TXN | ▲ Buy | Grant | 574 | $0 | 1/26/2023 | View on chart |
| GL | ▲ Buy | Grant | 1,422 | $0 | 1/3/2023 | View on chart |
| GL | ▼ Sell | Tax Withholding | 395 | $40K | 7/3/2022 | View on chart |
| GL | ▼ Sell | Tax Withholding | 64 | $7K | 5/4/2022 | View on chart |
| TXN | ▲ Buy | Option Exercise | 1,077 | $119K | 2/4/2022 | View on chart |
| TXN | ▲ Buy | Option Exercise | 978 | $128K | 2/4/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 845 | $143K | 2/4/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 635 | $108K | 2/4/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 464 | $78K | 2/4/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 1,650 | $283K | 2/4/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 501 | $86K | 2/4/2022 | View on chart |
| TXN | ▲ Buy | Option Exercise | 1,133 | $118K | 2/4/2022 | View on chart |
| EMR | ▲ Buy | Grant | 1,905 | — | 2/1/2022 | View on chart |
| TXN | ▲ Buy | Grant | 572 | $0 | 1/27/2022 | View on chart |
| GL | ▲ Buy | Grant | 1,791 | $0 | 1/3/2022 | View on chart |
| GL | ▲ Buy | Grant | 289 | $0 | 11/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Qnity Electronics sees new analyst coverage and dividend announcement
Qnity Electronics announced its fourth-quarter dividend while Truist Securities and Barclays initiated coverage with positive ratings. RBC Capital also maintained its Outperform rating but lowered its price target to $160. These updates provide fresh institutional perspectives on the company's outlook amid recent market volatility.
Qnity Electronics sees new analyst coverage and dividend announcement. Qnity Electronics announced its fourth-quarter dividend while Truist Securities and Barclays initiated coverage with positive ratings. RBC Capital also maintained its Outperform rating but lowered its price target to $160. These updates provide fresh institutional perspectives on the company's outlook amid recent market volatility.